3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
NET
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
699
Lung Neoplasms
297
Small Cell Lung Carcinoma
149
Colorectal Neoplasms
113
Melanoma
106
Neoplasms
93
Breast Neoplasms
93
Ovarian Neoplasms
92
Neoplasm Metastasis
85
Squamous Cell Carcinoma of Head and Neck
83
Stomach Neoplasms
81
Pancreatic Neoplasms
78
Carcinoma, Renal Cell
66
Triple Negative Breast Neoplasms
63
Esophageal Neoplasms
51
Endometrial Neoplasms
48
Uterine Cervical Neoplasms
47
Head and Neck Neoplasms
47
Mesothelioma
42
Mesothelioma, Malignant
41
Sarcoma
40
Prostatic Neoplasms
36
Urinary Bladder Neoplasms
34
Carcinoma, Transitional Cell
32
Colonic Neoplasms
31
Carcinoma, Hepatocellular
31
Adenocarcinoma of Lung
31
Carcinoma
26
Recurrence
21
Thyroid Neoplasms
20
Interventions
regorafenib
1
Clinical Trials, Phase II as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Tertiary Lymphoid Structures
×
Thoracic
×
Clear all
NCT03475953
2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2
Unknown
747 enrolled